Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine effect on insulin release in healthy men
NCT03972215Phase 1Completed
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Berberine treatment with Placebo control (2 arms). Primary endpoints: Serum insulin levels at 2 hours and Serum C-peptide levels at 2 hours. Started Oct 2019; status: completed.
02
Drugs
berberine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03972215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03972215.